HomeIndustry News › Peptides

Why Are People Injecting Themselves with Peptides? – The New Yorker

Peptides: Why Are People Injecting Themselves with Peptides? – The New Yorker

A growing number of people are turning to peptide injections, seeking benefits ranging from weight loss to anti-aging effects, according to a recent examination by The New Yorker. These short chains of amino acids, which serve as building blocks for proteins in the body, have moved from the fringes of biohacking communities into mainstream wellness culture, prompting questions about their safety and efficacy.

Peptides like semaglutide and tirzepatide have gained FDA approval for specific medical uses, particularly in diabetes and obesity treatment. However, The New Yorker’s investigation reveals that many individuals are self-administering various peptides obtained through online sources or compounding pharmacies, often without medical supervision. Some seek muscle growth and recovery, others pursue cognitive enhancement, while many hope to achieve the dramatic weight loss effects popularized by prescription GLP-1 medications.

The appeal lies partly in peptides’ biological nature—they’re molecules the body already produces or recognizes. Proponents argue this makes them safer than synthetic drugs, though medical experts warn this assumption is misguided. Without rigorous testing and FDA oversight, the purity, dosing, and actual contents of many peptide products remain uncertain.

The trend reflects broader shifts in how Americans approach health optimization, with wellness influencers and online communities sharing injection protocols and sourcing recommendations. This decentralized information network operates largely outside traditional medical channels, creating potential risks for consumers who may not fully understand what they’re injecting or the possible side effects.

For patients considering peptide therapies, medical professionals emphasize the importance of working with licensed healthcare providers who can prescribe FDA-approved formulations when appropriate. As regulatory bodies like the FDA continue evaluating which peptides should remain available through compounding pharmacies, the current landscape remains a patchwork of approved medications, gray-market products, and unverified wellness claims that consumers must navigate carefully.

← Previous Why Do a Significant Number of GLP-1 Users Stop Taking the Medication in the First Year? - Pharmaceutical Executive Next → Navigating menopause: Is hormone therapy right for you? - SSM Health

Get the Weekly Digest

Research highlights, community picks, and expert insights — every week.

← Back to All News

Popular telehealth providers in this space

Disclosure: The links below are affiliate links — if you click through and make a purchase, GLPbase may earn a small commission at no additional cost to you. This section does not constitute medical advice or a recommendation to seek treatment. Any healthcare decisions are solely between you and your provider. These links do not affect the article above, which is independently researched and written before any affiliate links are added. Our editorial team does not receive commissions, and our analysis is never influenced by affiliate partnerships. For more details, see our Editorial Policy.